FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells - PubMed (original) (raw)
. 2005 Feb 17;24(8):1434-44.
doi: 10.1038/sj.onc.1208312.
Affiliations
- PMID: 15608675
- DOI: 10.1038/sj.onc.1208312
FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells
Karine Belguise et al. Oncogene. 2005.
Abstract
Breast cancer progression is likely a multistep process involving the activation and inactivation of a number of genes. Previously, we showed that the mRNA coding for Fra-1, a FOS family member and an AP-1 transcription factor component, was highly expressed in the more invasive estrogen receptor negative (ER-) breast cancer cell lines. We used a tet-off system to stably overexpress Fra-1 in MCF7 ER+ cells and evaluate the impact of Fra-1 on this aggressive phenotype. Conversely, Fra-1 was silenced in highly invasive ER-MDA-MB231 cells using RNA interference. We report that in both systems the Fra-1 expression level was positively associated with cell proliferation, cell motility and invasiveness assessed in vitro. In addition, Fra-1 inhibition in fibroblastoid ER- cells, which formed colonies with large stellate projections in Matrigel, resulted in morphological changes. Cells acquired an epithelioid shape and had a spherical appearance in Matrigel. Fra-1 regulated several genes, implicated in invasion, angiogenesis and cell proliferation independently of beta1-integrin activation, and directly induced MMP-1 and MMP-9 promoter activity. These overall results show that high Fra-1 expression is associated with a more malignant cell phenotype and suggest that Fra-1 could have a pivotal role in breast cancer progression.
Similar articles
- Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
Milde-Langosch K, Janke S, Wagner I, Schröder C, Streichert T, Bamberger AM, Jänicke F, Löning T. Milde-Langosch K, et al. Breast Cancer Res Treat. 2008 Feb;107(3):337-47. doi: 10.1007/s10549-007-9559-y. Epub 2007 Mar 28. Breast Cancer Res Treat. 2008. PMID: 17393299 - Fos-related antigen 1 modulates malignant features of glioma cells.
Debinski W, Gibo DM. Debinski W, et al. Mol Cancer Res. 2005 Apr;3(4):237-49. doi: 10.1158/1541-7786.MCR-05-0004. Mol Cancer Res. 2005. PMID: 15831677 - Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S, Rittling SR, Partridge NC, Benson CS, Thiyagaraj M, Srinivasan N, Selvamurugan N. Kwok S, et al. J Cell Biochem. 2009 Oct 1;108(2):408-14. doi: 10.1002/jcb.22267. J Cell Biochem. 2009. PMID: 19582787 - Genes controlling spread of breast cancer to lung "gang of 4".
Eltarhouny SA, Elsawy WH, Radpour R, Hahn S, Holzgreve W, Zhong XY. Eltarhouny SA, et al. Exp Oncol. 2008 Jun;30(2):91-5. Exp Oncol. 2008. PMID: 18566569 Review. - Fra-1 a target for cancer prevention or intervention.
Young MR, Colburn NH. Young MR, et al. Gene. 2006 Sep 1;379:1-11. doi: 10.1016/j.gene.2006.05.001. Epub 2006 May 6. Gene. 2006. PMID: 16784822 Review.
Cited by
- Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY, Hsiao JR, Chang KC, Chang JS, Chen CW, Lai HC, Wu SY, Yeh TH, Chang FH, Lin WH, Su IJ, Chang Y. Lan YY, et al. J Virol. 2012 Jun;86(12):6656-67. doi: 10.1128/JVI.00174-12. Epub 2012 Apr 18. J Virol. 2012. PMID: 22514348 Free PMC article. - Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.
Desmet CJ, Gallenne T, Prieur A, Reyal F, Visser NL, Wittner BS, Smit MA, Geiger TR, Laoukili J, Iskit S, Rodenko B, Zwart W, Evers B, Horlings H, Ajouaou A, Zevenhoven J, van Vliet M, Ramaswamy S, Wessels LF, Peeper DS. Desmet CJ, et al. Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5139-44. doi: 10.1073/pnas.1222085110. Epub 2013 Mar 12. Proc Natl Acad Sci U S A. 2013. PMID: 23483055 Free PMC article. - AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins.
Spence HJ, McGarry L, Chew CS, Carragher NO, Scott-Carragher LA, Yuan Z, Croft DR, Olson MF, Frame M, Ozanne BW. Spence HJ, et al. Mol Cell Biol. 2006 Feb;26(4):1480-95. doi: 10.1128/MCB.26.4.1480-1495.2006. Mol Cell Biol. 2006. PMID: 16449658 Free PMC article. - Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells.
Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H, Oka M, Imai K, Dahiya R, Hinoda Y. Ueno K, et al. Br J Cancer. 2009 Oct 20;101(8):1374-81. doi: 10.1038/sj.bjc.6605307. Epub 2009 Sep 22. Br J Cancer. 2009. PMID: 19773752 Free PMC article. - FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders.
Chiappetta G, Ferraro A, Botti G, Monaco M, Pasquinelli R, Vuttariello E, Arnaldi L, Di Bonito M, D'Aiuto G, Pierantoni GM, Fusco A. Chiappetta G, et al. BMC Cancer. 2007 Jan 25;7:17. doi: 10.1186/1471-2407-7-17. BMC Cancer. 2007. PMID: 17254320 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous